Literature DB >> 25016214

Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.

Valentina Biasin1, Karolina Chwalek2, Jochen Wilhelm2, Johannes Best2, Leigh M Marsh1, Bahil Ghanim3, Walter Klepetko4, Ludger Fink5, Ralph T Schermuly2, Norbert Weissmann2, Andrea Olschewski6, Grazyna Kwapiszewska7.   

Abstract

Pulmonary hypertension (PH) is characterized by enhanced pulmonary artery smooth muscle cell (PASMC) proliferation leading to vascular remodeling. Although, multiple factors have been associated with pathogenesis of PH the underlying mechanisms are not fully understood. Here, we hypothesize that already very short exposure to hypoxia may activate molecular cascades leading to vascular remodeling. Microarray studies from lung homogenates of mice exposed to only 3h of hypoxia revealed endothelin-1 (ET-1) and connective tissue growth factor (CTGF) as the most upregulated genes, and the mitogen-activated protein kinase (MAPK) pathway as the most differentially regulated pathway. Evaluation of these results in vitro showed that ET-1 but not CTGF stimulation of human PASMCs increased DNA synthesis and expression of proliferation markers such as Ki67 and cell cycle regulator, cyclin D1. Moreover, ET-1 treatment elevated extracellular signal-regulated kinase (Erk)-dependent c-fos expression and phosphorylation of c-fos and c-jun transcription factors. Silencing of c-fos with siRNA abrogated the ET-1-induced proliferation of PASMCs. Expression and immunohistochemical analyses revealed higher levels of total and phosphorylated c-fos and c-jun in the vessel wall of lung samples of human idiopathic pulmonary arterial hypertension patents, hypoxia-exposed mice and monocrotaline-treated rats as compared to control subjects. These findings shed the light on the involvement of c-fos/c-jun in the proliferative response of PASMCs to ET-1 indicating that already very short hypoxia exposure leads to the regulation of mediators involved in vascular remodeling underlying PH.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endothelin-1; Proliferation; Pulmonary hypertension; Transcription factor; c-Fos

Mesh:

Substances:

Year:  2014        PMID: 25016214     DOI: 10.1016/j.biocel.2014.06.020

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

1.  Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.

Authors:  Terry W Moody; Irene Ramos-Alvarez; Paula Moreno; Samuel A Mantey; Lisa Ridnour; David Wink; Robert T Jensen
Journal:  Peptides       Date:  2017-01-31       Impact factor: 3.750

Review 2.  Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).

Authors:  Soni S Pullamsetti; Frédéric Perros; Prakash Chelladurai; Jason Yuan; Kurt Stenmark
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

3.  Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Authors:  Raymond L Benza; Mardi Gomberg-Maitland; Teresa Demarco; Adaani E Frost; Adam Torbicki; David Langleben; Tomas Pulido; Priscilla Correa-Jaque; Michael J Passineau; Howard W Wiener; Mayumi Tamari; Tomomitsu Hirota; Michiaki Kubo; Hemant K Tiwari
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

4.  Hot topics in the mechanisms of pulmonary arterial hypertension disease: cancer-like pathobiology, the role of the adventitia, systemic involvement, and right ventricular failure.

Authors:  Edda Spiekerkoetter; Elena A Goncharova; Christophe Guignabert; Kurt Stenmark; Grazyna Kwapiszewska; Marlene Rabinovitch; Norbert Voelkel; Harm J Bogaard; Brian Graham; Soni S Pullamsetti; Wolfgang M Kuebler
Journal:  Pulm Circ       Date:  2019-11-20       Impact factor: 3.017

5.  Comprehensive Analyses of miRNA-mRNA Network and Potential Drugs in Idiopathic Pulmonary Arterial Hypertension.

Authors:  Chan Li; Zeyu Zhang; Qian Xu; Ruizheng Shi
Journal:  Biomed Res Int       Date:  2020-07-03       Impact factor: 3.411

6.  Novel sericin-based hepatocyte serum-free medium and sericin's effect on hepatocyte transcriptome.

Authors:  Yun Huang; Qing Peng; Hai-Yan Li; Zhi-Dong Jia; Yang Li; Yi Gao
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

7.  Fra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent Manner.

Authors:  Anna Gungl; Valentina Biasin; Jochen Wilhelm; Andrea Olschewski; Grazyna Kwapiszewska; Leigh M Marsh
Journal:  Front Immunol       Date:  2018-09-05       Impact factor: 7.561

Review 8.  Microarray analysis in pulmonary hypertension.

Authors:  Julia Hoffmann; Jochen Wilhelm; Andrea Olschewski; Grazyna Kwapiszewska
Journal:  Eur Respir J       Date:  2016-04-13       Impact factor: 16.671

9.  Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus.

Authors:  Özlem Atlı; Sinem Ilgın; Bülent Ergun; Dilek Burukoğlu; Ahmet Musmul; Başar Sırmagül
Journal:  Anatol J Cardiol       Date:  2016-04-26       Impact factor: 1.596

Review 10.  Pulmonary Hypertension in Intensive Care Units: An Updated Review.

Authors:  Armin Nowroozpoor; Majid Malekmohammad; Seyyed Reza Seyyedi; Seyed Mohammadreza Hashemian
Journal:  Tanaffos       Date:  2019-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.